|
End-of-day quote
Shanghai S.E.
28/09/2026
|
5-day change | 1st Jan Change | ||
| 13.44 CNY | -0.30% |
|
-1.18% | +14.87% |
| 28/08 | Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 26/05 | Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement | MT |
| Market Cap | 543.97Cr 81Cr 71Cr 67Cr 61Cr 114.78Cr 7.78TCr 115.45Cr 806.8Cr 311.59Cr 3.97TCr 304.19Cr 297.6Cr 13TCr | P/E 2024 |
19.4x | P/E 2025 | 106x |
|---|---|---|---|---|---|
| Enterprise Value | 578.84Cr 86Cr 76Cr 72Cr 65Cr 122.14Cr 8.28TCr 122.85Cr 858.52Cr 331.57Cr 4.22TCr 323.69Cr 316.68Cr 14TCr | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 2.99x |
| Free-Float |
40.62% | Yield 2024 |
2.62% | Yield 2025 | 0.51% |
| 1 day | -0.30% | ||
| 1 week | -1.18% | ||
| Current month | +12.28% | ||
| 1 month | +7.78% | ||
| 3 months | +1.51% | ||
| 6 months | +21.74% | ||
| Current year | +14.87% |
| 1 week | 13.12 |  | 14.68 |
| 1 month | 10.91 | | 15.17 |
| Current year | 9.51 | | 17.46 |
| 1 year | 9.51 | | 17.46 |
| 3 years | 9.51 | | 20.34 |
| 5 years | 9.51 | | 21.28 |
| 10 years | 8.82 | | 44.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Fan Zhang
CEO | Chief Executive Officer | 41 | 27/05/2024 |
Hai Zhang
CEO | Chief Executive Officer | 41 | 01/09/2011 |
Ke Guo
DFI | Director of Finance/CFO | 39 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Shi Gui Chen
BRD | Director/Board Member | 63 | 12/12/2022 |
Wei Sheng Feng
BRD | Director/Board Member | 66 | 10/10/2024 |
Hai Zhang
CHM | Chairman | 41 | 01/03/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/09/24 | Sell | Chief Executive Officer | 2,10,00,000 | 5.1428% | ||
| 02/08/24 | Buy | Director | 13,000 | 0.0032% | ||
| 05/08/23 | Sell | 25,000 | 0.0061% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.30% | -1.18% | +6.25% | -22.18% | 81Cr | |
| +0.11% | +2.76% | +63.52% | +115.51% | 1,05500Cr | |
| +0.27% | +0.73% | +51.33% | +73.10% | 65TCr | |
| +0.73% | +0.88% | +20.70% | +73.89% | 47TCr | |
| -1.36% | -0.39% | +40.20% | +41.03% | 35TCr | |
| +1.34% | +5.47% | +23.37% | +31.30% | 27TCr | |
| -0.48% | -0.06% | +13.56% | +12.36% | 26TCr | |
| +0.85% | +6.35% | +52.62% | +54.39% | 22TCr | |
| +0.85% | +1.10% | +35.15% | +101.82% | 19TCr | |
| -0.30% | -10.41% | -27.62% | -61.04% | 17TCr | |
| Average | +0.27% | +0.01% | +27.91% | +42.02% | 36.39TCr | |
| Weighted average by Cap. | +0.28% | +1.31% | +40.62% | +68.98% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 214.44Cr 32Cr 28Cr 27Cr 24Cr 45Cr 3.07TCr 46Cr 318.05Cr 122.83Cr 1.56TCr 119.91Cr 117.32Cr 5.03TCr | 170.28Cr 25Cr 22Cr 21Cr 19Cr 36Cr 2.43TCr 36Cr 252.56Cr 98Cr 1.24TCr 95Cr 93Cr 3.99TCr |
| Net income | 27Cr 4.08Cr 3.59Cr 3.39Cr 3.08Cr 5.78Cr 391.79Cr 5.82Cr 41Cr 16Cr 199.92Cr 15Cr 15Cr 642.44Cr | 4.63Cr 68.89L 60.59L 57.3L 51.97L 97.6L 66Cr 98.17L 6.86Cr 2.65Cr 34Cr 2.59Cr 2.53Cr 108.44Cr |
| Net Debt | 11Cr 1.6Cr 1.41Cr 1.33Cr 1.21Cr 2.27Cr 153.93Cr 2.29Cr 16Cr 6.17Cr 79Cr 6.02Cr 5.89Cr 252.42Cr | 35Cr 5.19Cr 4.57Cr 4.32Cr 3.92Cr 7.36Cr 498.57Cr 7.4Cr 52Cr 20Cr 254.41Cr 19Cr 19Cr 817.53Cr |
Employees
1,887
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | CN¥13.44 | -0.30% | 1,42,87,980 |
| 24/26/24 | CN¥13.48 | -2.88% | 1,18,63,700 |
| 23/26/23 | CN¥13.88 | -4.01% | 1,50,80,324 |
| 22/26/22 | CN¥14.46 | +0.56% | 3,00,96,676 |
| 21/26/21 | CN¥14.38 | +5.74% | 3,69,67,900 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603439 Stock
Select your edition
All financial news and data tailored to specific country editions
